BDBM411339 US10385031, Compound 045::US10774056, Compound 045::US11542242, Compound 045

SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1cccnc1

InChI Key InChIKey=KZDNQOITFZOHEG-UHFFFAOYSA-N

Data  9 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 411339   

TargetHistone deacetylase 1(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411339(US10385031, Compound 045 | US10774056, Compound 04...)
Affinity DataIC50: <1.00E+3nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 2(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411339(US10385031, Compound 045 | US10774056, Compound 04...)
Affinity DataIC50: <1.00E+3nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 3(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411339(US10385031, Compound 045 | US10774056, Compound 04...)
Affinity DataIC50: <1.00E+3nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 1(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411339(US10385031, Compound 045 | US10774056, Compound 04...)
Affinity DataIC50:  255nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 3(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411339(US10385031, Compound 045 | US10774056, Compound 04...)
Affinity DataIC50:  255nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 3(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411339(US10385031, Compound 045 | US10774056, Compound 04...)
Affinity DataIC50:  255nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 1(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411339(US10385031, Compound 045 | US10774056, Compound 04...)
Affinity DataIC50:  255nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 2(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411339(US10385031, Compound 045 | US10774056, Compound 04...)
Affinity DataIC50:  255nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone deacetylase 2(Homo sapiens (Human))
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM411339(US10385031, Compound 045 | US10774056, Compound 04...)
Affinity DataIC50:  255nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent